Doripenem

This classification denotes a beta-lactam antibiotic with the molecular formula C15H24N4O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BHV525JOBH, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as doripenem, which bears US NIH Compound Identifier 73303. European Medicines Agency schedules Doripenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22196. The term DORIPENEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules doripenem in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule doripenem under HS 29419000 and SITC 54139. As of Q4 2014, DORIPENEM remains the US FDA Preferred Term for this commodity. Doripenem bears US NLM identifiers UMLS ID C0389169 and NCI Concept Code C65470. SMILES: S(C1=C(N2C(C(C2=O)C(O)C)C1C)C(=O)O)C1CC(NC1)CNS(=O)(=O)N.